Explore
Trendline
Vanda Pharmaceuticals Reports Q1 2026 Financial Results Highlighting Growth and New Product Launches
Vanda Pharmaceuticals Reports Q1 2026 Financial Results Highlighting Growth and New Product Launches
Read More
Trendline
Innoviva Reports Strong Q1 2026 Financial Results Amid Strategic Growth
Innoviva Reports Strong Q1 2026 Financial Results Amid Strategic Growth
Read More
Trendline
Supernus Pharmaceuticals Reports Strong Revenue Growth Despite Earnings Miss
Supernus Pharmaceuticals Reports Strong Revenue Growth Despite Earnings Miss
Read More
Trendline
Bruker Corporation Reports Q1 2026 Financial Results with Revenue Growth
Bruker Corporation Reports Q1 2026 Financial Results with Revenue Growth
Read More
Trendline
EPAM Systems Reports Strong Q1 2026 Financial Results Amid AI Transformation
EPAM Systems Reports Strong Q1 2026 Financial Results Amid AI Transformation
Read More
Trendline
Weis Markets Reports 4.6% Revenue Increase in Q1 2026 Amid Strategic Investments
Weis Markets Reports 4.6% Revenue Increase in Q1 2026 Amid Strategic Investments
Read More
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Expansion Plans
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Expansion Plans
Read More
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Read More
Trendline
Supernus Pharmaceuticals Reports Q1 CY2026 Sales Surpassing Expectations Despite Earnings Miss
Supernus Pharmaceuticals Reports Q1 CY2026 Sales Surpassing Expectations Despite Earnings Miss
Read More
Trendline
Thomson Reuters Reports Strong Q1 2026 Financial Results with Revenue Growth
Thomson Reuters Reports Strong Q1 2026 Financial Results with Revenue Growth
Read More
Trendline
Sarepta, Amylyx, and Neumora Anticipate Key Developments Amidst Q1 Earnings
Sarepta, Amylyx, and Neumora Anticipate Key Developments Amidst Q1 Earnings
Read More
Trendline
Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results
Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results
Read More
